Association Between Primary School Children's Speaking Attitudes and Oral Health Indicators

November 26, 2025 updated by: Ezgi Turkyilmaz

Association Between Primary School Children's Speaking Attitudes and Oral Health Indicators: A Cross-Sectional Study

his cross-sectional study aims to evaluate the relationship between primary school children's speaking attitudes and oral health indicators, including dental caries, malocclusion, and tooth loss. A total of 184 children aged 7-12 years participated. Sociodemographic data, oral examination findings, and Speaking Attitudes Scale for Children (SASC) scores were collected. The study seeks to identify whether oral health problems influence children's self-perceived communication confidence and to emphasize the importance of integrating oral health awareness into early educational settings.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This cross-sectional observational study was conducted to assess the association between primary school children's speaking attitudes and their oral health status. The study included 184 children aged 7-12 years who underwent intraoral examinations to record dental caries (dmft/DMFT indices), malocclusion, and tooth loss. The Speaking Attitudes Scale for Children (SASC) was used to evaluate children's attitudes toward their speaking skills. Data were analyzed to explore correlations between SASC scores and oral health indicators. The findings are expected to provide insight into how oral health conditions, such as untreated caries or malocclusion, may influence children's communication confidence and social participation. Ethical approval for this study was obtained from the Erciyes University Clinical Research Ethics Committee (Approval No: 2024/211).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
184

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This study included 184 primary school children aged 7 to 12 years who were attending public schools in Turkey. Both male and female children were included. Participants represented a generally healthy pediatric population without chronic medical conditions.

Description

Inclusion Criteria:

  • Children aged 7-12 years enrolled in primary schools Children who are native Turkish speakers Children without systemic or developmental disorders Children and parents who provided informed consent to participate

Exclusion Criteria:

  • hildren with speech or hearing impairments Children with fixed orthodontic appliances Children with missing permanent first molars due to extraction Children with a history of craniofacial anomalies or trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Single Observational Group
All participants were included in a single observational group to evaluate the relationship between speaking attitudes and oral health indicators in primary school children.
Other: Observational Assessment
This is an observational study with no intervention applied. Data were collected through clinical oral examinations and self-administered questionnaires assessing speaking attitudes and oral health-related variables.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Association between speaking attitude scores and oral health indicators
Time Frame: Single assessment at baseline (cross-sectional study)
Single assessment at baseline (cross-sectional study)
ssociation between speaking attitude scores and oral health indicators
Time Frame: Single assessment at baseline (cross-sectional study)
The primary outcome was the relationship between speaking attitude scores (measured by the Speaking Attitude Scale for Primary School Children) and oral health indicators such as dental caries experience (DMFT/dmft), malocclusion, and tooth loss. Higher speaking attitude scores indicate more positive speaking attitudes.
Single assessment at baseline (cross-sectional study)
Association between speaking attitude scores and oral health indicators
Time Frame: Single assessment at baseline (cross-sectional study)
The primary outcome was the relationship between speaking attitude scores (measured by the Speaking Attitude Scale for Primary School Children) and oral health indicators such as dental caries experience (DMFT/dmft), malocclusion, and tooth loss. Higher speaking attitude scores indicate more positive speaking attitudes.
Single assessment at baseline (cross-sectional study)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Relationship between oral health status and sociodemographic factors
Time Frame: Single assessment at baseline
Secondary analysis included evaluating the association between children's oral health indicators (DMFT/dmft, malocclusion, tooth loss) and sociodemographic factors such as age, gender, and parental education level.
Single assessment at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Ezgi Turkyilmaz

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 1, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 30, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 26, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 26, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 9, 2025

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 9, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 26, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • ERU-PEDO-2025-01
  • 2024/211 (Other Identifier: ERCIYES UNIVERSITY)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings